New insights on premature ejaculation: A review of definition, classification, prevalence and treatment

Asian Journal of Andrology

Volumn 14, Issue 6, 2012, Pages 822-829

  Serefoglu, Ege C ^a   Saitz, Theodore R ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

definition; ejaculatory disorders epidemiology; premature ejaculation; sexual dysfunction; treatment

Indexed keywords

ANESTHETIC AGENT; PHOSPHODIESTERASE V INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ACUPUNCTURE; BEHAVIOR THERAPY; DISEASE SEVERITY; HEALTH SURVEY; HUMAN; INTERNET; INTERVIEW; MALE; OUTCOME ASSESSMENT; PREMATURE EJACULATION; PREVALENCE; PSYCHOTHERAPY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

ANIMALS; BENZYLAMINES; COITUS; HUMANS; LIDOCAINE; MALE; NAPHTHALENES; PIPERAZINES; PREMATURE EJACULATION; PREVALENCE; PRILOCAINE; PURINES; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SULFONES;

EID: 84869066607     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2012.108     Document Type: Review

References (114)

1. Gross S. Practical Treatise on Impotence and Sterility and Allied Disorders of the Male Sexual Organs. Edinburg: YJ Pentland; 1887.
2. Althof SE, Abdo CH, Dean J, Hackett G, McCabe M et al. International Society for Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation. J Sex Med 2010; 7: 2947-69.
3. Jannini EA, Lombardo F, Lenzi A. Correlation between ejaculatory and erectile dysfunction. Int J Androl 2005; 28 (Suppl 2): 40-5. (Pubitemid 41719772)
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Text Revision. Washington, DC: American Psychiatric Publishing, Inc.; 1980.
5. World Health Organization. International Classification of Diseases and Related Health Problems, 10th edition. Geneva: World Health Organization; 1994.
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Text Revision, 4th edition. Washington, DC: American Psychiatric Publishing, Inc.; 2000.
7. Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH et al. A multinational population survey of intravaginal ejaculation latency time. J Sex Med 2005; 2: 492-7. (Pubitemid 40975833)
8. McMahon CG, Althof S, Waldinger MD, Porst H, Dean J et al. An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation.BJU Int 2008; 102: 338-50. (Pubitemid 352019206)
9. MastersWH, Johnson VE. Human Sexual Inadequacy. Boston,MA: Little & Brown; 1970.
10. Waldinger MD. Recent advances in the classification, neurobiology and treatment of premature ejaculation. Adv Psychosom Med 2008; 29: 50-69.
11. Waldinger MD, Schweitzer DH. Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation. Part II - proposals for DSM-V and ICD-11. J Sex Med 2006; 3: 693-705.
12. Waldinger MD, Schweitzer DH. Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation. Part I - validity of DSM-IV-TR. J Sex Med 2006; 3: 682-92.
13. Shapiro B. Premature ejaculation: a review of 1130 cases. J Urol 1943; 50: 6.
14. Godpodinoff ML. Premature ejaculation: clinical subgroups and etiology. J Sex Marital Ther 1989; 15: 130-4. (Pubitemid 19213787)
15. Basile Fasolo C, Mirone V, Gentile V, Parazzini F, Ricci E. Premature ejaculation: prevalence and associated conditions in a sample of 12,558 men attending the andrology prevention week 2001 - a study of the Italian Society of Andrology (SIA). J Sex Med 2005; 2: 376-82. (Pubitemid 40744378)
16. Serefoglu EC, Yaman O, Cayan S, Asci R, Orhan I et al. The comparison of premature ejaculation assessment questionnaires and their sensitivity for the four premature ejaculation syndromes: results from the Turkish society of andrology sexual health survey. J Sex Med 2011; 8: 1177-85.
17. Serefoglu EC, Yaman O, Cayan S, Asci R, Orhan I et al. Prevalence of the complaint of ejaculating prematurely and the four premature ejaculation syndromes: results from the Turkish Society of Andrology Sexual Health Survey. J Sex Med 2011; 8: 540-8.
18. Serefoglu EC, Cimen HI, Atmaca AF, Balbay MD. The distribution of patients who seek treatment for the complaint of ejaculating prematurely according to the four premature ejaculation syndromes. J Sex Med 2010; 7: 810-5.
19. Patrick DL, Althof SE, Pryor JL, Rosen R, Rowland DL et al. Premature ejaculation: an observational study of men and their partners. J Sex Med 2005; 2: 358-67. (Pubitemid 40744376)
20. Pryor JL, Althof SE, Steidle C, Rosen RC, Hellstrom WJ et al. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet 2006; 368: 929-37. (Pubitemid 44331385)
21. Giuliano F, Patrick DL, Porst H, la Pera G, Kokoszka A et al. Premature ejaculation: results from a five-country European observational study. EurUrol 2008; 53: 1048-57. (Pubitemid 351434498)
22. Porst H, McMahon CG, Althof SE, Sharlip I, Bull S et al. Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: integrated analyses of two phase 3 dapoxetine trials. J Sex Med 2010; 7: 2231-42.
23. Park HJ, Park JK, Park K, Lee SW, Kim SW et al. Prevalence of premature ejaculation in young and middle-aged men in Korea: a multicenter internet-based survey from the Korean Andrological Society. Asian J Androl 2010; 12: 880-9.
24. Dunn KM, Croft PR, Hackett GI. Sexual problems: a study of the prevalence and need for health care in the general population. Fam Pract 1998; 15: 519-24. (Pubitemid 29084073)
25. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281: 537-44. (Pubitemid 29081307)
26. Fugl-Meyer K, Fugl-Meyer AR. Sexual disabilities are not singularities. Int J Impot Res 2002; 14: 487-93. (Pubitemid 36068426)
27. Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005; 17: 39-57. (Pubitemid 40299993)
28. Porst H, Montorsi F, Rosen RC, Gaynor L, Grupe S et al. The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol 2007; 51: 816-23; discussion 824.
29. Brock GB, Benard F, Casey R, Elliott SL, Gajewski JB et al. Canadian male sexual health council survey to assess prevalence and treatment of premature ejaculation in Canada. J Sex Med 2009; 6: 2115-23.
30. Traeen B, Stigum H. Sexual problems in 18-67-year-old Norwegians. Scand J Public Health 2010; 38: 445-56.
31. Amidu N, Owiredu WK, Woode E, Addai-Mensah O, Gyasi-Sarpong KC et al. Prevalence of male sexual dysfunction among Ghanaian populace: myth or reality? Int J Impot Res 2010; 22: 337-42.
32. Liang CZ, Hao ZY, Li HJ, Wang ZP, Xing JP et al. Prevalence of premature ejaculation and its correlation with chronic prostatitis in Chinese men. Urology 2010; 76: 962-6.
33. Christensen BS, Gronbaek M, Osler M, Pedersen BV, Graugaard C et al. Sexual dysfunctions and difficulties in denmark: prevalence and associated sociodemographic factors. Arch Sex Behav 2011; 40: 121-32.
34. Vakalopoulos I, Dimitriadis G, Varnava C, Herodotou Y, Gkotsos G et al. Prevalence of ejaculatory disorders in urban men: results of a random-sample survey. Andrologia 2011; 43: 327-33.
35. Tang WS, Khoo EM. Prevalence and correlates of premature ejaculation in a primary care setting: a preliminary cross-sectional study. J Sex Med 2011; 8: 2071-8.
36. Shaeer O, Shaeer K. The Global Online Sexuality Survey (GOSS): ejaculatory function, penile anatomy, and contraceptive usage among Arabic-speaking Internet users in the Middle East. J Sex Med 2012; 9: 425-33.
37. Shindel AW, Vittinghoff E, Breyer BN. Erectile dysfunction and premature ejaculation in men who have sex with men. J Sex Med 2012; 9: 576-84.
38. McMahon CG, Lee G,Park JK,Adaikan PG.Premature ejaculation and erectile dysfunction prevalence and attitudes in the Asia-Pacific region. J Sex Med 2012; 9: 454-65.
39. Rowland D, Perelman M, Althof S, Barada J, McCullough A et al. Self-reported premature ejaculation and aspects of sexual functioning and satisfaction. J Sex Med 2004; 1: 225-32. (Pubitemid 40424658)
40. Nolazco C, Bellora O, Lopez M, Surur D, Vazquez J et al. Prevalence of sexual dysfunctions in Argentina. Int J Impot Res 2004; 16: 69-72. (Pubitemid 38401562)
41. Stulhofer A, Bajic Z. Prevalence of erectile and ejaculatory difficulties among men in Croatia. Croat Med J 2006; 47: 114-24. (Pubitemid 43326909)
42. Waldinger MD. The neurobiological approach to premature ejaculation. J Urol 2002; 168: 2359-67. (Pubitemid 35402615)
43. Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol 2010; 57: 804-14.
44. Lujan S, Garcia-Fadrique G, Morales G, Morera J, Broseta E et al. Are urology residents ready to treat premature ejaculation after their training? J Sex Med 2012; 9: 404-10.
45. Hellstrom WJ. Update on treatments for premature ejaculation. Int J Clin Pract 2011; 65: 16-26.
46. Xin ZC, Zhu YC, Yuan YM, Cui WS, Jin Z et al. Current therapeutic strategies for premature ejaculation and future perspectives. Asian J Androl 2011; 13: 550-7.
47. Giuliano F, Clement P. Pharmacology for the treatment of premature ejaculation. Pharmacol Rev 2012; 64: 621-44.
48. Melnik T, Althof S, Atallah AN, Puga ME, Glina S et al. Psychosocial interventions for premature ejaculation. Cochrane Database Syst Rev 2011: CD008195.
49. Rowland D, Cooper S. Practical tips for sexual counseling and psychotherapy in premature ejaculation. J Sex Med 2011; 8 (Suppl 4): 342-52.
50. Lee J. Potential Risks for the off-label use of SSRIs in premature ejaculation (CME). J Sex Med 2010; 7: 2622-4; quiz 2625.
51. Abdo CH, Afif-Abdo J, Otani F, Machado AC. Exualsatisfactionamongpatientswitherectile dysfunction treated with counseling, sildenafil, or both. JSexMed2008; 5: 1720-6. (Pubitemid 352044428)
52. Aubin S, Heiman JR, Berger RE, Murallo AV, Yung-Wen L. Comparing Sildenafil alone vs. Sildenafil plus brief couple sex therapy on erectile dysfunction and couples' sexual and marital quality of life: a pilot study. J Sex Marital Ther 2009; 35: 122-43.
53. Melnik T, Abdo CH. Psychogenic erectile dysfunction: comparative study of three therapeutic approaches. J Sex Marital Ther 2005; 31: 243-55. (Pubitemid 40594095)
54. Steggall MJ, Flower CG, Pryce A. Combination therapy for premature ejaculation: results of a small-scale study. Sex Rel Ther 2008; 23: 365-76.
55. Semans JH. Premature ejaculation: a new approach. South Med J 1956; 49: 353-8.
56. de Carufel F, Trudel G. Effects of a new functional-sexological treatment for premature ejaculation. J Sex Marital Ther 2006; 32: 97-114. (Pubitemid 43111851)
57. Pastore AL, Palleschi G, Leto A, Pacini L, Iori F et al. A prospective randomized study to compare pelvic floor rehabilitation and dapoxetine for treatment of lifelong premature ejaculation. Int J Androl 2012; 35: 528-33.
58. Hartmann UH. Words of wisdom. Re: Effects of a new functional-sexological treatment for premature ejaculation. Eur Urol 2007; 52: 1259-61.
59. Atikeler MK, Gecit I, Senol FA. Optimum usage of prilocaine-lidocaine cream in premature ejaculation. Andrologia 2002; 34: 356-9. (Pubitemid 35463780)
60. Atan A, Basar MM, Tuncel A, Ferhat M, Agras K et al. Comparison of efficacy of sildenafil-only, sildenafil plus topical EMLA cream, and topical EMLA-cream-only in treatment of premature ejaculation. Urology 2006; 67: 388-91. (Pubitemid 43189862)
61. Dinsmore WW, Hackett G, Goldmeier D, Waldinger M, Dean J et al. Topical eutectic mixture for premature ejaculation (TEMPE): a novel aerosol-delivery form of lidocaineprilocaine for treating premature ejaculation.BJU Int 2007; 99: 369-75. (Pubitemid 46103119)
62. Mohee A, Eardley I. Medical therapy for premature ejaculation. Ther Adv Urol 2011; 3: 211-22.
63. Morales A, Barada J, Wyllie MG. A review of the current status of topical treatments for premature ejaculation. BJU Int 2007; 100: 493-501. (Pubitemid 47205483)
64. Choi HK, Jung GW, Moon KH, Xin ZC, Choi YD et al. Clinical study of SS-cream in patients with lifelong premature ejaculation. Urology 2000; 55: 257-61. (Pubitemid 30069927)
65. Giuliano F, Clement P. Serotonin and premature ejaculation: from physiology to patient management. Eur Urol 2006; 50: 454-66. (Pubitemid 44189074)
66. Kwon OY, Kam SC, Choi JH, Do JM, Hyun JS. Effects of sertraline on brain current source of the high beta frequency band: analysis of electroencephalography during audiovisual erotic stimulation in males with premature ejaculation. Int J Impot Res 2011; 23: 213-9.
67. Giuliano F. 5-Hydroxytryptamine in premature ejaculation: opportunities for therapeutic intervention. Trends Neurosci 2007; 30: 79-84. (Pubitemid 46164860)
68. Waldinger MD. Premature ejaculation: definition and drug treatment. Drugs 2007; 67: 547-68. (Pubitemid 46440312)
69. Waldinger MD. Lifelong premature ejaculation: definition, serotonergic neurotransmission and drug treatment. World J Urol 2005; 23: 102-8. (Pubitemid 41051499)
70. Giuliano F. Premature ejaculation: definition and drug treatment. Drugs 2007; 67: 1629-30. (Pubitemid 47267300)
71. Waldinger MD, Zwinderman AH, Schweitzer DH, Olivier B. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res 2004; 16: 369-81. (Pubitemid 39273766)
72. Waldinger MD, Zwinderman AH, Olivier B. SSRIs and ejaculation: a double-blind, randomized, fixed-dose study with paroxetine and citalopram. J Clin Psychopharmacol 2001; 21: 556-60. (Pubitemid 33116653)
73. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol 1998; 18: 274-81. (Pubitemid 28353869)
74. Koyuncu H, Serefoglu EC, Ozdemir AT, Hellstrom WJ. Deleterious effects of selective serotonin reuptake inhibitor treatment on semen parameters in patients with lifelong premature ejaculation. Int J Impot Res 2012; 24: 171-3.
75. Koyuncu H, Serefoglu EC, Yencilek E, Atalay H, Akbas NB et al. Escitalopram treatment for premature ejaculation has a negative effect on semen parameters. Int J Impot Res 2011; 23: 257-61.
76. Tanrikut C, Feldman AS, Altemus M, Paduch DA, Schlegel PN. Adverse effect of paroxetine on sperm. Fertil Steril 2010; 94: 1021-6.
77. Tanrikut C, Schlegel PN. Antidepressant-associated changes in semen parameters. Urology 2007; 69: 185-7.
78. Safarinejad MR. Sperm DNA damage and semen quality impairment after treatment with selective serotonin reuptake inhibitors detected using semen analysis and sperm chromatin structure assay. J Urol 2008; 180: 2124-8.
79. Angulo J, Peiro C, Sanchez-Ferrer CF, Gabancho S, Cuevas P et al. Differential effects of serotonin reuptake inhibitors on erectile responses, NO-production, and neuronal NO synthase expressionin rat corpus cavernosumtissue.Br J Pharmacol2001;134:1190-4. (Pubitemid 33097248)
80. Kadioglu M, Muci E, Ozyavuz R, Yaris E, Kesim M et al. Paroxetine inhibited the relaxations induced by EFS in mice corpus cavernosum: is it a NOS inhibition? Fundam Clin Pharmacol 2010; 24: 55-61.
81. Bolton JM, Sareen J, Reiss JP. Genital anaesthesia persisting six years after sertraline discontinuation. J Sex Marital Ther 2006; 32: 327-30. (Pubitemid 43995228)
82. Csoka AB, Bahrick A, Mehtonen OP. Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors. J Sex Med 2008; 5: 227-33.
83. McMahon CG, Althof SE, Kaufman JM, Buvat J, Levine SB et al. Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials. J Sex Med 2011; 8: 524-39.
84. Buvat J, Tesfaye F, Rothman M, Rivas DA, Giuliano F. Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries. Eur Urol 2009; 55: 957-67.
85. Dresser MJ, Desai D, Gidwani S, Seftel AD, Modi NB. Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors. Int J Impot Res 2006; 18: 104-10. (Pubitemid 43050030)
86. Hutchinson K, Cruickshank K, Wylie K. A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation. Drug Saf 2012; 35: 359-72.
87. Waldinger MD, Zwinderman AH, Olivier B, Schweitzer DH. The majority of men with lifelong premature ejaculation prefer daily drug treatment: an observation study in a consecutive group of Dutch men. J Sex Med 2007; 4: 1028-37. (Pubitemid 47079636)
88. Waldinger MD, Schweitzer DH. Premature ejaculation and pharmaceutical companybased medicine: the dapoxetine case. J Sex Med 2008; 5: 966-97.
89. McMahon CG, Stuckey BG, Andersen M, Purvis K, Koppiker N et al. Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation. J Sex Med 2005; 2: 368-75. (Pubitemid 40744377)
90. McMahon CG, McMahon CN, Leow LJ, Winestock CG. Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: a systematic review.BJU Int 2006; 98: 259-72.
91. Wang WF, Minhas S, Ralph DJ. Phosphodiesterase 5 inhibitors in the treatment of premature ejaculation. Int J Androl 2006; 29: 503-9. (Pubitemid 44350960)
92. Gokce A, Halis F, Demirtas A, Ekmekcioglu O. The effects of three phosphodiesterase type 5 inhibitors on ejaculation latency time in lifelong premature ejaculators: a double-blind laboratory setting study.BJU Int 2011; 107: 1274-7.
93. F Sommer TK, MJ Mathers. Treatment of premature ejaculation: a comparative vardenafil and SSRI crossover study. J Urol 2005; 173: 1.
94. Asimakopoulos AD, Miano R, Agro EF, Vespasiani G, Spera E. Does current scientific and clinical evidence support the use of phosphodiesterase type 5 inhibitors for the treatment of premature ejaculation? A systematic review and meta-analysis. J Sex Med 2012; 9: 2404-16.
95. Jannini EA, McMahon C, Chen J, Aversa A, Perelman M. The controversial role of phosphodiesterase type 5 inhibitors in the treatment of premature ejaculation. J Sex Med 2011; 8: 2135-43.
96. Basar MM, Yilmaz E, Ferhat M, Basar H, Batislam E. Terazosin in the treatment of premature ejaculation: a short-term follow-up. Int Urol Nephrol 2005; 37: 773-7. (Pubitemid 43124245)
97. Cavallini G. Alpha-1 blockade pharmacotherapy in primitive psychogenic premature ejaculation resistant to psychotherapy. Eur Urol 1995; 28: 126-30.
98. Sato Y, Tanda H, Nakajima H, Nitta T, Akagashi K et al. Silodosin and its potential for treating premature ejaculation: a preliminary report. Int J Urol 2012; 19: 268-72.
99. Safarinejad MR, Hosseini SY. Safety and efficacy of tramadol in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. J Clin Psychopharmacol 2006; 26: 27-31. (Pubitemid 43167087)
100. Salem EA, Wilson SK, Bissada NK, Delk JR, Hellstrom WJ et al. Tramadol HCL has promise in on-demand use to treat premature ejaculation. J SexMed 2008; 5: 188-93.
101. Kaynar M, Kilic O, Yurdakul T. On-demand tramadol hydrochloride use in premature ejaculation treatment. Urology 2012; 79: 145-9.
102. Bar-Or D, Salottolo KM, Orlando A, Winkler JV. A randomized double-blind, placebocontrolled multicenter study to evaluate the efficacy and safety of two doses of the tramadol orally disintegrating tablet for the treatment of premature ejaculation within less than 2 minutes. Eur Urol 2012; 61: 736-43.
103. Ho CC. Re: David Bar-Or, Kristin M. Salottolo, Alessandro Orlando, James V. Winkler. A randomized double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of two doses of the tramadol orally disintegrating tablet for the treatment of premature ejaculation within less than 2 minutes. Eur Urol 2012; 61: 736-43. Eur Urol 2012; 61: e23-4; author reply e25-6.
104. Giuliano FA. Tramadol for the treatment of premature ejaculation. Eur Urol 2012; 61: 744-5.
105. Wu X, Zhou Z. Re: Didem Sunay, Melih Sunay, Yasin Aydogmus, et al. Acupuncture versus paroxetine for the treatment of premature ejaculation: a randomized, placebocontrolled clinical trial. Eur Urol 2011; 59: 765-71. Eur Urol 2011; 60: e27.
106. Sunay D, Sunay M, Aydogmus Y, Bagbanci S, Arslan H et al. Acupuncture versus paroxetine for the treatment of premature ejaculation: a randomized, placebocontrolled clinical trial. Eur Urol 2011; 59: 765-71.
107. Kwak TI, Jin MH, Kim JJ, Moon DG. Long-term effects of glans penis augmentation using injectable hyaluronic acid gel for premature ejaculation. Int J Impot Res 2008; 20: 425-8.
108. Abdallah H, Abdelnasser T, Hosny H, Selim O, Al-Ahwany A et al. Treatment of premature ejaculation by glans penis augmentation using hyaluronic acid gel: a pilot study. Andrologia 2012; 44 (Suppl 1): 650-3.
109. Namavar MR, Robati B. Removal of foreskin remnants in circumcised adults for treatment of premature ejaculation. Urol Ann 2011; 3: 87-92.
110. Buvat J. Pathophysiology of premature ejaculation. J Sex Med 2011; 8 (Suppl 4): 316-27.
111. Graziottin A, Althof S. What does premature ejaculation mean to the man, the woman, and the couple? J Sex Med 2011; 8 (Suppl 4): 304-9.
112. Moncada I. The importance of follow-up in patients with premature ejaculation. J Sex Med 2011; 8 (Suppl 4): 353-9.
113. Jannini EA, Maggi M, Lenzi A. Evaluation of premature ejaculation. J Sex Med 2011; 8 (Suppl 4): 328-34.
114. McMahon CG. Clinical trial methodology in premature ejaculation observational, interventional, and treatment preference studies-part I-defining and selecting the study population. J Sex Med 2008; 5: 1805-16.